Health Care & Life Sciences » Pharmaceuticals | Agile Therapeutics Inc.

Agile Therapeutics Inc. | Ownership

Companies that own Agile Therapeutics Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Perceptive Advisors LLC
3,231,372
9.4%
-298,628
0.02%
07/26/2018
The Vanguard Group, Inc.
1,081,945
3.15%
54,158
0%
06/30/2018
Renaissance Technologies LLC
792,990
2.31%
343,290
0%
06/30/2018
Franklin Advisers, Inc.
611,500
1.78%
-2,743,700
0%
06/30/2018
RBC Capital Markets LLC (Investment Management)
358,737
1.04%
47,069
0%
06/30/2018
Needham Investment Management LLC
246,325
0.72%
-181,219
0.02%
06/30/2018
Geode Capital Management LLC
185,857
0.54%
14,539
0%
06/30/2018
Apo Asset Management GmbH
123,000
0.36%
30,000
0%
06/29/2018
Bridgeway Capital Management, Inc.
122,000
0.36%
-72,300
0%
06/30/2018
DWS Investment GmbH
110,600
0.32%
109,267
0%
06/30/2018

About Agile Therapeutics

View Profile
Address
101 Poor Farm Road
Princeton New Jersey 08540
United States
Employees -
Website http://www.agiletherapeutics.com
Updated 07/08/2019
Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patch for use in contraception. It offers its product candidate Twirla, which is an investigational non-daily prescription contraceptive. The company was founded by Chien Te Yen on December 22, 1997 and is headquartered in Princeton, NJ.